Chief Scientific Officer Sergey Dryga to present the Tbit™ system: a new blood test for the rapid identification of concussion and other traumatic brain injury
April 8, 2015
Boston, MA – (BUSINESS WIRE) – BioDirection, Inc., a privately-held medical device company focused on the development and commercialization of easy-to-use, rapid, point-of-care devices for the objective identification of acquired brain injury including concussion, today announced it will present at the 5th annual Traumatic Brain Injury Conference being held in Washington, DC on April 16, 2015. The company’s Tbit™ system delivers objective information to aid in the diagnosis of a concussion from a single drop of blood in less than 90 seconds. Additionally, this technology provides emergency room physicians with new actionable data that can help in reducing unnecessary head CT scans, thereby saving time and expense while eliminating radiation exposure to the patient.
Sergey Dryga, Ph.D., MBA, Chief Scientific Officer of BioDirection, will be presenting on BioDirection’s new Tbit™ system. "This revolutionary blood test will provide new point-of-care information to significantly improve how concussions and other traumatic brain injury are diagnosed today," asserts Dryga. "Our evaluation of the Tbit™ system suggests that the sensitivity and specificity is superior to existing methods while providing results in less than two minutes."
Event: The 5th annual Traumatic Brain Injury Conference
Presentation: Thursday, April 16, 2015, 11:40 am (EST
Location: 10 Thomas Circle N.W. Washington, DC, Washington Plaza Hotel
BioDirection is a privately-held medical device company focused on the development and commercialization of rapid, point-of-care devices for the objective diagnosis, prognosis and status of acquired brain injury. BioDirection’s multiplexing platform utilizes patented bio-sensing nanowire technology that can detect and measure minute levels of "biomarker" proteins released from the brain after a concussion or other traumatic brain injury.
For more information visit: www.biodirection.com
Now in its 5th year, Arrowhead's Annual Traumatic Brain Injury Conference brings together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury. This event provides a special opportunity for a variety of stakeholders to present original research and analysis aimed at providing a full picture of the progress being made towards better diagnosis, treatment and long-term care for TBI survivors.
BioDirection and Tbit are registered trademarks of BioDirection, Inc.
James A. Wylie, Executive Chairman
Tel: (203) 240-1319
Eric Goorno, President & CEO
Tel: (508) 308-8592
BioDirection is always searching for new opportunities. Contact us today with any questions or inquiries.